Mustang Bio (MBIO) Retained Earnings (2015 - 2026)

Mustang Bio (MBIO) has reported Retained Earnings for 12 consecutive years, with -$400.7 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Retained Earnings fell 0.77% year-over-year to -$400.7 million in Q2 2026; TTM through Jun 2026 was -$400.7 million, a 0.77% decrease from a year earlier, with the FY2025 full-year figure at -$398.6 million, changed 0.48% from the prior year.
• Retained Earnings was -$400.7 million for Q2 2026 at Mustang Bio, roughly flat from -$399.6 million in the prior quarter.
• Over five years, Retained Earnings peaked at -$271.6 million in Q1 2022 and troughed at -$400.7 million in Q2 2026.
• A 5-year average of -$368.2 million and a median of -$390.3 million in 2024 frame the typical range for Retained Earnings.
• Across the five-year window, Retained Earnings sank 35.53% in 2022 and decreased 0.48% in 2025, its largest moves.
• Over 5 years, Retained Earnings stood at -$329.4 million in 2022, then fell by 15.67% to -$381.0 million in 2023, then dropped by 4.13% to -$396.7 million in 2024, then fell by 0.48% to -$398.6 million in 2025, then dropped by 0.52% to -$400.7 million in 2026.
• The last three Retained Earnings figures came in at -$400.7 million (Q2 2026), -$399.6 million (Q1 2026), and -$398.6 million (Q4 2025), per Business Quant data.